Amgen's (AMGN) once-monthly GLP-1, which experts expect to be a game changer in the weight-loss space, is showing continued promise as it advances in clinical trials. The company reported 20% ...

Topline. The Federal Trade Commission announced Friday it had reached a settlement with Amgen Inc. over the biopharmaceutical firm’s $27.8 billion acquisition of Horizon Therapeutics, after the ...

As for Amgen’s stalwarts, osteoporosis treatment Prolia had an 8% increase year over year to $1 billion. Meanwhile, rheumatoid arthritis drug Enbrel—which is one of 10 products identified for ...

Amgen agreed in the proposed settlement to not bundle the Horizon treatments and swore off conditional rebates or other tactics that could entrench the monopoly position of Horizon’s products ...

As Amgen's business grows and it generates more revenue from new products, its free cash should also improve, paving the way for the business to chip away at its debt. How much of a dent it can ...